Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14486118 | 1.00 | CHRNB2 (0.33) | CHRNB2CHRNB4CHRNA3CHRNA4SLC7A5 | |
| SCHEMBL995487 | 0.89 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL27906557 | 0.89 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL11061010 | 0.89 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2A | |
| Serine SCHEMBL16031031 | 0.88 | PDCD1LG2 (0.36) | SLC7A5ALOX15BLMPMP22KMT2A | |
| SCHEMBL6130798 | 0.86 | SLC7A5 (0.48) | SLC7A5 | |
| SCHEMBL4958595 | 0.86 | SLC7A5 (0.48) | SLC7A5 | |
| SCHEMBL4775852 | 0.86 | SLC7A5 (0.48) | SLC7A5 | |
| SCHEMBL8002645 | 0.84 | — | — | |
| SCHEMBL8712673 | 0.84 | SLC7A5 (0.37) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760775-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. | 2023-09-19 | — | — | US | disclosed |
| CN-115844896-A | Methods of treating arenaviridae and coronaviridae virus infections | 吉利德科学公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2021-02-11 | — | — | US | disclosed |
| EP-3737420-A2 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2020-11-18 | — | — | EP | disclosed |
| US-10369091-B2 | Core shell silica particles and uses thereof as an anti-bacterial agent | COLGATE-PALMOLIVE COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| WO-2019136487-A2 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2019-07-11 | — | — | WO | disclosed |
| US-20160338920-A1 | CORE SHELL SILICA PARTICLES AND USES THEREOF AS AN ANTI-BACTERIAL AGENT | COLGATE PALMOLIVE CO (US) | 2016-11-24 | — | — | US | disclosed |
| CN-1895066-A | Anti-body leben tablet (powder) | GOU CHUNHU (CN) | 2007-01-17 | — | — | CN | disclosed |
| US-5747050-A | COSMETICS WITH SODIUM CHLORIDE AND PEAT | TORF ESTABLISHMENT (LI) | 1998-05-05 | — | — | US | disclosed |
| US-5428171-A | Leukotrienes antagonist; antiasthmatic, antiallergic, anti-inflammatory and cytoprotective agent | MERCK FROSST CANADA, INC. (CA) | 1995-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160338920-A1 | CORE SHELL SILICA PARTICLES AND USES THEREOF AS AN ANTI-BACTERIAL AGENT | SRI, CAPG, SAE1 | CHRNB2 4707/4885CHRNB4 4627/4885CHRNA3 4677/4885 |
| US-10369091-B2 | Core shell silica particles and uses thereof as an anti-bacterial agent | SRI, CAPG, SAE1 | CHRNB2 4707/4885CHRNB4 4627/4885CHRNA3 4677/4885 |
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | CHRNB2 1887/4885CHRNB4 2197/4885CHRNA3 3675/4885 |
| US-11760775-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | CHRNB2 1887/4885CHRNB4 2197/4885CHRNA3 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.